查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829644

2025年全球凝血标记物市场报告

Coagulation Markers Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，凝血标记市场规模强劲成长，从2024年的11.6亿美元成长到2025年的12.4亿美元，复合年增长率为6.2%。这段历史时期的成长可归因于心血管疾病盛行率的上升、人口老化、外科手术的增加、意识提升的提高和早期诊断的提升、政府的倡议和资金投入，以及医疗基础设施的不断扩张。

预计未来几年凝血标记市场将强劲成长，到2029年将达到15.9亿美元，复合年增长率为6.5%。预测期内成长的驱动因素包括慢性病盛行率的上升、个人化医疗的普及、全球人口的成长、医疗保健支出的增加以及新兴市场的扩张。预测期内的主要趋势包括人工智慧和机器学习的整合、新型生物标记的开发、增强型照护现场技术、实验室自动化、穿戴式医疗技术、远端医疗和远端监控以及永续的诊断方法。

凝血标记是血液中能够反映凝血或血液凝固过程的物质。这些标记在诊断和监测各种凝血障碍、评估出血和血栓症形成风险以及指南适当的治疗策略方面发挥着重要作用。

用作凝血标誌物的关键产品包括 D-二聚体检测和纤维蛋白原检测。 D-二聚体检测是一种血液检测，用于测量 D-二聚体的存在，D-二聚体是血栓分解过程中形成的蛋白质片段。它们采用萤光免疫分析、酵素结合免疫吸附检测法(ELISA)、快速检测法和颗粒增强免疫比浊检测法等技术，可用于多种检体类型，包括血浆和全血。应用包括深层静脉栓塞症血栓形成 (DVT)、肺动脉栓塞(PE)、瀰漫性血管内凝血 (DIC) 和创伤。这些检测的最终用户包括医院、专科诊所、学术研究机构和诊断实验室。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供了凝血标誌物行业的市场统计数据，包括全球市场规模、区域份额、竞争对手的市场份额、详细的凝血标誌物细分市场、市场趋势和机会，以及在凝血标誌物行业取得成功所需的数据。本凝血标誌物市场研究报告对行业现状和未来进行了全面展望，并对所有必要资讯进行了详细分析。

我们预测未来五年该市场将成长6.5%，较我们先前对该市场的预测略有下降0.4%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自瑞士和比利时等主要地区的D-二聚体抗体和纤维蛋白原校准标准品征收关税直接影响美国，从而导致出血性疾病的诊断准确性降低和检测成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

由于血液疾病的盛行率不断上升，预计凝血标记市场将大幅成长。这些疾病涵盖一系列影响血液正常运作能力的状况，由于人口老化、认知度提高和诊断能力增强等因素，其盛行率正在上升。凝血标记在这些疾病的诊断和管理中发挥关键作用，包括评估血液凝固功能、检测异常以及监测血友病和血栓症等治疗的有效性。例如，白血病基金会在2024年5月报告称，预计到2035年，澳洲患有血癌和血病的人数将超过27.5万人，这凸显了对凝血标誌物日益增长的需求。

凝血标誌物市场的主要企业正专注于开发技术先进的解决方案，例如 D-二聚体套件，以提高诊断血栓相关疾病的速度和准确性。 D-二聚体试剂套件是用于测量深层静脉栓塞症水平的诊断工具，D-二聚体是血栓溶解过程中产生的蛋白质片段，有助于识别和评估血栓相关疾病，如深部静脉栓塞和肺动脉栓塞。例如，2024 年 7 月，美国生技公司 Bionotex Inc. 推出了 Vcheck D-dimer 5Tests/Kit。这种专为兽医设计的免疫诊断工具每个套件提供五项测试来测量 D-二聚体水平，这是血栓形成和分解的关键标记。它可用于诊断血栓症、败血症、DIC 和兽医诊所的其他疾病。

2023年1月，美国生技公司赛默飞世尔科技（Thermo Fisher Scientific）以约28亿美元（23亿英镑）收购了Binding Site Group。此次收购旨在增强赛默飞世尔的专业诊断产品组合，增强癌症诊断（尤其是多发性骨髓瘤诊断）能力，并推动不断扩大的诊断市场的成长。 Binding Site Group是一家英国医疗设备製造商，专门提供凝血标誌物。

凝血标誌物市场由提供凝血标记检测套组製造和销售、诊断服务、新型凝血标誌物研发和咨询服务等服务的企业所获得的收益所构成。市场价值还包括服务提供者销售的或包含在其服务产品中的相关产品的价值。凝血标誌物市场还包括血液凝固检验套件、就地检验设备以及数据管理和分析软体解决方案的销售。该市场的价值是“出厂价”，即商品製造商或创造者销售给其他营业单位（包括下游製造商、经销商、分销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球固化指标：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球凝血标誌物市场：成长率分析
  • 全球凝血标誌物市场表现：规模与成长，2019-2024
  • 全球凝血标誌物市场预测：规模与成长，2024-2029年，2034年
  • 全球凝血标记：总目标市场（TAM）

第六章 市场细分

  • 全球凝血标记市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • D-二聚体测定
  • 纤维蛋白原测定
  • 全球凝血标记市场（按样本类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 电浆
  • 全血样本
  • 其他样本类型
  • 全球凝血标记市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 萤光免疫分析法
  • 酵素结合免疫吸附试验（ELISA）
  • 快速检测
  • 粒子增强免疫比浊法
  • 全球凝血标记市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 深层静脉栓塞症（DVT）
  • 肺动脉栓塞（PE）
  • 瀰漫性血管内凝血（DIC）
  • 创伤
  • 其他用途
  • 全球凝血标记市场：按最终用户、业绩和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专科诊所
  • 学术研究机构
  • 诊断实验室
  • 全球凝血标记市场：D-二聚体检测细分（按类型）、实际及预测（2019-2024 年、2024-2029 年、2034 年）
  • 基于ELISA的D-二聚体检测
  • 侧流免疫检测D-二聚体检测
  • 化学冷光免疫检测D-二聚体检测
  • 全球凝血标记市场：依纤维蛋白原检测（按类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 克劳斯纤维蛋白原测定
  • 功能性纤维蛋白原测定
  • 自动化纤维蛋白原测定

第七章 区域和国家分析

  • 全球凝血标记市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球凝血标记市场：按国家、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 凝血标誌物市场：竞争格局
  • 凝血标誌物市场：公司简介
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Werfen Group
  • Nihon Kohden Corporation
  • Randox Laboratories Ltd
  • Stago Group
  • Sekisui Diagnostics
  • Helena Laboratories Italia Spa
  • Tulip Diagnostics Ltd
  • Trinity Biotech PLC
  • CTK Biotech Inc.
  • International Technidyne Corporation（ITC）
  • Diazyme Laboratories Inc.
  • AdvaCare Pharma USA（AccuQuik Test Kits）
  • Technoclone GmbH

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年凝血标记市场：提供新机会的国家
  • 2029年凝血标誌物市场：细分市场带来新机会
  • 2029年凝血标记市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29821u

Coagulation markers are substances in the blood that provide insight into the coagulation or clotting processes. These markers play a crucial role in diagnosing and monitoring various coagulation disorders, assessing the risk of bleeding or thrombosis, and guiding appropriate treatment strategies.

The main products used as coagulation markers include the D-dimer assay and the fibrinogen assay. The D-dimer assay is a blood test that measures the presence of D-dimer, a protein fragment formed when a blood clot breaks down. This test can utilize different sample types such as plasma or whole blood, employing technologies such as fluorescence immunoassay, enzyme-linked immunosorbent assay (ELISA), rapid tests, and particle-enhanced immunoturbidimetric assay. It is applied in conditions such as deep venous thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), trauma, and others. End users of these assays include hospitals, specialty clinics, academic and research institutes, and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The coagulation markers market research report is one of a series of new reports from The Business Research Company that provides coagulation markers market statistics, including coagulation markers industry global market size, regional shares, competitors with a coagulation markers market share, detailed coagulation markers market segments, market trends and opportunities, and any further data you may need to thrive in the coagulation markers industry. This coagulation markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The coagulation markers market size has grown strongly in recent years. It will grow from $1.16 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the rising prevalence of cardiovascular diseases, an aging population, increasing surgical procedures, awareness and early diagnosis, government initiatives and funding, and expanding healthcare infrastructure.

The coagulation markers market size is expected to see strong growth in the next few years. It will grow to $1.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to a growing incidence of chronic diseases, rising adoption of personalized medicine, a growing global population, rising healthcare expenditures, and expansion in emerging markets. Major trends in the forecast period include the integration of AI and machine learning, the development of novel biomarkers, enhanced point-of-care technologies, automation in laboratories, wearable health technologies, telehealth and remote monitoring, and sustainable diagnostic practices.

The forecast of 6.5% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on D-dimer antibodies and fibrinogen calibration standards, sourced from key regions such as Switzerland and Belgium, which could lead to reduced accuracy in bleeding disorder diagnoses and higher laboratory testing expenses.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The coagulation markers market is expected to grow significantly due to the increasing prevalence of blood disorders. These disorders encompass various conditions that impact the blood's ability to function properly, and their prevalence is rising due to factors such as aging populations, improved awareness, and enhanced diagnostic capabilities. Coagulation markers play a crucial role in diagnosing and managing these disorders by evaluating clotting function, detecting abnormalities, and monitoring treatment effectiveness for conditions such as hemophilia and thrombosis. For example, the Leukaemia Foundation reported in May 2024 that the number of Australians living with blood cancers or disorders is projected to surpass 275,000 by 2035, highlighting the escalating demand for coagulation markers.

Leading companies in the coagulation markers market are focusing on creating technologically advanced solutions, such as D-dimer kits, to enhance the speed and accuracy of diagnosing blood clot-related conditions. D-dimer kits are diagnostic tools used to measure the levels of D-dimer, a protein fragment produced during the dissolution of a blood clot, which helps in identifying and evaluating clot-related disorders like deep vein thrombosis and pulmonary embolism. For example, in July 2024, Bionote Inc., a US-based biotechnology firm, launched the Vcheck D-dimer 5Tests/Kit. This immunodiagnostic tool, designed for veterinary use, provides five tests per kit to measure D-dimer levels, a key marker for blood clot formation and breakdown. It helps diagnose conditions such as thrombosis, sepsis, and DIC in veterinary clinics.

In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for approximately $2.8 billion (£2.3 billion). This acquisition aims to strengthen Thermo Fisher's Specialty Diagnostics portfolio by enhancing cancer diagnostics, particularly in multiple myeloma, and driving growth in the expanding diagnostics market. The Binding Site Group, a UK-based medical equipment manufacturer, specializes in providing coagulation markers.

Major companies operating in the coagulation markers market are Siemens Healthineers, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Werfen Group, Nihon Kohden Corporation, Randox Laboratories Ltd, Stago Group, Sekisui Diagnostics, Helena Laboratories Italia Spa, Tulip Diagnostics Ltd, Trinity Biotech PLC, CTK Biotech Inc., International Technidyne Corporation (ITC), Diazyme Laboratories Inc., AdvaCare Pharma USA (AccuQuik Test Kits), Technoclone GmbH, BioMedica Diagnostics Inc., Eurolyser Diagnostica GmbH, Goldsite Diagnostics Inc., Hipro Biotechnology Co. Ltd., HYPHEN BioMed

North America was the largest region in the coagulation markers market in 2024. The regions covered in the coagulation markers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coagulation markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coagulation markers market consists of revenues earned by entities providing services such as manufacturing and distribution of coagulation marker testing kits, diagnostic services, research and development of new coagulation markers, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The coagulation markers market also includes sales of coagulation testing kits, point-of-care testing devices, and software solutions for data management and analysis. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coagulation Markers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coagulation markers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coagulation markers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coagulation markers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: D-Dimer Assay; Fibrinogen Assay
  • 2) By Sample Type: Plasma; Whole Blood Sample; Other Sample Types
  • 3) By Technology: Fluorescence Immunoassay; Enzyme-Linked Immuno Sorbent Assay (ELISA); Rapid Test; Particle Enhanced Immunoturbidimetric Assay
  • 4) By Application: Deep Venous Thrombosis (DVT); Pulmonary Embolism (PE); Disseminated Intravascular Coagulation (DIC); Trauma; Other Applications
  • 5) By End User: Hospital; Specialty Clinics; Academic And Research Institute; Diagnostics Laboratories
  • Subsegments:
  • 1) By D-Dimer Assay: ELISA-Based D-Dimer Assay; Lateral Flow Immunoassay D-Dimer Test; Chemiluminescent Immunoassay D-Dimer Test
  • 2) By Fibrinogen Assay: Clauss Fibrinogen Assay; Functional Fibrinogen Assay; Automated Fibrinogen Assay
  • Companies Mentioned: Siemens Healthineers; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Quidel Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; Werfen Group; Nihon Kohden Corporation; Randox Laboratories Ltd; Stago Group; Sekisui Diagnostics; Helena Laboratories Italia Spa; Tulip Diagnostics Ltd; Trinity Biotech PLC; CTK Biotech Inc.; International Technidyne Corporation (ITC); Diazyme Laboratories Inc.; AdvaCare Pharma USA (AccuQuik Test Kits); Technoclone GmbH; BioMedica Diagnostics Inc.; Eurolyser Diagnostica GmbH; Goldsite Diagnostics Inc.; Hipro Biotechnology Co. Ltd.; HYPHEN BioMed
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Coagulation Markers Market Characteristics

3. Coagulation Markers Market Trends And Strategies

4. Coagulation Markers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Coagulation Markers Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Coagulation Markers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Coagulation Markers Market Growth Rate Analysis
  • 5.4. Global Coagulation Markers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Coagulation Markers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Coagulation Markers Total Addressable Market (TAM)

6. Coagulation Markers Market Segmentation

  • 6.1. Global Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • D-Dimer Assay
  • Fibrinogen Assay
  • 6.2. Global Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasma
  • Whole Blood Sample
  • Other Sample Types
  • 6.3. Global Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluorescence Immunoassay
  • Enzyme-Linked Immuno Sorbent Assay (ELISA)
  • Rapid Test
  • Particle Enhanced Immunoturbidimetric Assay
  • 6.4. Global Coagulation Markers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deep Venous Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Disseminated Intravascular Coagulation (DIC)
  • Trauma
  • Other Applications
  • 6.5. Global Coagulation Markers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Specialty Clinics
  • Academic and Research Institute
  • Diagnostics Laboratories
  • 6.6. Global Coagulation Markers Market, Sub-Segmentation Of D-Dimer Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • ELISA-Based D-Dimer Assay
  • Lateral Flow Immunoassay D-Dimer Test
  • Chemiluminescent Immunoassay D-Dimer Test
  • 6.7. Global Coagulation Markers Market, Sub-Segmentation Of Fibrinogen Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clauss Fibrinogen Assay
  • Functional Fibrinogen Assay
  • Automated Fibrinogen Assay

7. Coagulation Markers Market Regional And Country Analysis

  • 7.1. Global Coagulation Markers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Coagulation Markers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Coagulation Markers Market

  • 8.1. Asia-Pacific Coagulation Markers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Coagulation Markers Market

  • 9.1. China Coagulation Markers Market Overview
  • 9.2. China Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Coagulation Markers Market

  • 10.1. India Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Coagulation Markers Market

  • 11.1. Japan Coagulation Markers Market Overview
  • 11.2. Japan Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Coagulation Markers Market

  • 12.1. Australia Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Coagulation Markers Market

  • 13.1. Indonesia Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Coagulation Markers Market

  • 14.1. South Korea Coagulation Markers Market Overview
  • 14.2. South Korea Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Coagulation Markers Market

  • 15.1. Western Europe Coagulation Markers Market Overview
  • 15.2. Western Europe Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Coagulation Markers Market

  • 16.1. UK Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Coagulation Markers Market

  • 17.1. Germany Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Coagulation Markers Market

  • 18.1. France Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Coagulation Markers Market

  • 19.1. Italy Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Coagulation Markers Market

  • 20.1. Spain Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Coagulation Markers Market

  • 21.1. Eastern Europe Coagulation Markers Market Overview
  • 21.2. Eastern Europe Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Coagulation Markers Market

  • 22.1. Russia Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Coagulation Markers Market

  • 23.1. North America Coagulation Markers Market Overview
  • 23.2. North America Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Coagulation Markers Market

  • 24.1. USA Coagulation Markers Market Overview
  • 24.2. USA Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Coagulation Markers Market

  • 25.1. Canada Coagulation Markers Market Overview
  • 25.2. Canada Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Coagulation Markers Market

  • 26.1. South America Coagulation Markers Market Overview
  • 26.2. South America Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Coagulation Markers Market

  • 27.1. Brazil Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Coagulation Markers Market

  • 28.1. Middle East Coagulation Markers Market Overview
  • 28.2. Middle East Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Coagulation Markers Market

  • 29.1. Africa Coagulation Markers Market Overview
  • 29.2. Africa Coagulation Markers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Coagulation Markers Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Coagulation Markers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Coagulation Markers Market Competitive Landscape And Company Profiles

  • 30.1. Coagulation Markers Market Competitive Landscape
  • 30.2. Coagulation Markers Market Company Profiles
    • 30.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Coagulation Markers Market Other Major And Innovative Companies

  • 31.1. Sysmex Corporation
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Werfen Group
  • 31.4. Nihon Kohden Corporation
  • 31.5. Randox Laboratories Ltd
  • 31.6. Stago Group
  • 31.7. Sekisui Diagnostics
  • 31.8. Helena Laboratories Italia Spa
  • 31.9. Tulip Diagnostics Ltd
  • 31.10. Trinity Biotech PLC
  • 31.11. CTK Biotech Inc.
  • 31.12. International Technidyne Corporation (ITC)
  • 31.13. Diazyme Laboratories Inc.
  • 31.14. AdvaCare Pharma USA (AccuQuik Test Kits)
  • 31.15. Technoclone GmbH

32. Global Coagulation Markers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coagulation Markers Market

34. Recent Developments In The Coagulation Markers Market

35. Coagulation Markers Market High Potential Countries, Segments and Strategies

  • 35.1 Coagulation Markers Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Coagulation Markers Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Coagulation Markers Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer